首页> 外文期刊>Health and Quality of Life Outcomes >Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
【24h】

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

机译:腹泻型肠易激综合征患者的肠易激综合征生活质量(IBS-QOL)调查表的评估

获取原文
           

摘要

Background Diarrhea-predominant irritable bowel syndrome (IBS-d) significantly diminishes the health-related quality of life (HRQOL) of patients. Psychological and social impacts are common with many IBS-d patients reporting comorbid depression, anxiety, decreased intimacy, and lost working days. The Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire is a 34-item instrument developed and validated for measurement of HRQOL in non-subtyped IBS patients. The current paper assesses this previously-validated instrument employing data collected from 754 patients who participated in a randomized clinical trial of a novel treatment, eluxadoline, for IBS-d. Methods Psychometric methods common to HRQOL research were employed to evaluate the IBS-QOL. Many of the historical analyses of the IBS-QOL validations were used. Other techniques that extended the original methods were applied where more appropriate for the current dataset. In IBS-d patients, we analyzed the items and substructure of the IBS-QOL via item reduction, factor structure, internal consistency, reproducibility, construct validity, and ability to detect change. Results This study supports the IBS-QOL as a psychometrically valid measure. Factor analyses suggested that IBS-specific QOL as measured by the IBS-QOL is a unidimensional construct. Construct validity was further buttressed by significant correlations between IBS-QOL total scores and related measures of IBS-d severity including the historically-relevant Irritable Bowel Syndrome Adequate Relief (IBS-AR) item and the FDA’s Clinical Responder definition. The IBS-QOL also showed a significant ability to detect change as evidenced by analysis of treatment effects. A minority of the items, unrelated to the IBS-d, performed less well by the standards set by the original authors. Conclusions We established that the IBS-QOL total score is a psychometrically valid measure of HRQOL in IBS-d patients enrolled in this study. Our analyses suggest that the IBS-QOL items demonstrate very good construct validity and ability to detect changes due to treatment effects. Furthermore, our analyses suggest that the IBS-QOL items measure a univariate construct and we believe further modeling of the IBS-QOL from an item response theory (IRT) approach under both non-treatment and treatment conditions would greatly further our understanding as item-based methods could be used to develop a short form.
机译:背景腹泻型肠易激综合症(IBS-d)大大降低了患者的健康相关生活质量(HRQOL)。心理和社会影响在许多IBS-d患者中很常见,这些患者报告并存抑郁,焦虑,亲密感降低和工作日减少。肠易激综合症生活质量调查表(IBS-QOL)是一项34项工具,已开发并经过验证,可用于测量非亚型IBS患者的HRQOL。本论文使用从754名患者中收集的数据评估了这种先前验证的仪器,这些患者参加了针对IBS-d的新疗法eluxadoline的随机临床试验。方法采用HRQOL研究常用的心理计量学方法评估IBS-QOL。使用了许多IBS-QOL验证的历史分析。在更适合当前数据集的位置应用了扩展原始方法的其他技术。在IBS-d患者中,我们通过项目减少,因素结构,内部一致性,可重复性,构建效度和检测变化的能力来分析IBS-QOL的项目和子结构。结果本研究支持IBS-QOL作为心理上有效的度量。因子分析表明,由IBS-QOL测量的IBS特定QOL是一维结构。 IBS-QOL总分与IBS-d严重程度的相关度量(包括历史相关肠易激综合征充分缓解(IBS-AR)项目和FDA临床响应者定义)之间的显着相关性进一步提高了结构的有效性。通过对治疗效果的分析,IBS-QOL还显示出显着的检测变化的能力。与IBS-d无关的少数项目在原始作者设定的标准下表现不佳。结论我们确定,IBS-QOL总分是这项研究中IBS-d患者的HRQOL的心理计量学有效量度。我们的分析表明,IBS-QOL项目具有很好的构建效度和检测由于治疗效果引起的变化的能力。此外,我们的分析表明,IBS-QOL项目可测量单变量构造,并且我们认为,根据项目反应理论(IRT)方法在非治疗和治疗条件下对IBS-QOL进行的进一步建模将极大地增进我们对项目的理解,基于方法的方法可用于开发简短形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号